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Abstract Pseudomonas aeruginosa is one of the pathogenic
bacteria which utilize binding of the host plasminogen (Plg) to
promote their invasion throughout the host tissues. In the
present study, we confirmed that P. aeruginosa exhibits bind-
ing affinity for human plasminogen. Furthermore, we showed
that the protein detected on the cell wall of P. aeruginosa and
binding human plasminogen is an enolase-like protein. The
hypothesis that alpha-enolase, a cytoplasmatic glycolytic en-
zyme, resides also on the cell surface of the bacterium was
supported by electron microscopy analysis. The plasminogen-
binding activity of bacterial cell wall outer membrane enolase-
like protein was examined by immunoblotting assay.
Introduction
Pseudomonas aeruginosa, a widespread opportunistic patho-
gen, belongs to the Gram-negative non-fermenting bacteria of
Pseudomonadaceae family. It is an etiologic agent of several
respiratory, urinary, and gastrointestinal infections. Out of
several known factors determining its pathogenicity, the
exopolysaccharide mucus (glycocalyx) seems to be of greatest
importance. It plays a prime role in cellular adhesion and
persistent bacterial colonization of the epithelium and other
cells. Furthermore, it exhibits immunogenic properties.
P. aeruginosa secretes a number of cytotoxic exoenzymes,
such as phospholipid-cleaving phospholipase C and proteases
degrading the host’s proteins (Lomholt et al. 2001). The
bacterium is particularly dangerous for immunocompromised
individuals. Scientific reports suggest P. aeruginosa as the
most important pathogen and causal agent of chronic pulmo-
nary infections in patients with cystic fibrosis, which leads to
gradual and eventually fatal decline in pulmonary function
(Govan and Deretic 1996). P. aeruginosa shows low suscep-
tibility to many classes of antibiotics (Hancock and Speert
2000; Jo et al. 2003). Immunoprophylaxis and immunothera-
py (vaccines for the immunocompromised and passive immu-
nization with hyperimmune sera) are the most promising and
therefore of highest interest. Over many years, efforts to
produce effective vaccines against P. aeruginosawere focused
on two factors playing an important role in the bacterial
pathogenicity: carbohydrate structures represented by lipo-
polysaccharides and polysaccharides of the bacterial cellular
capsules and proteinaceous components of their external
membranes (Campbell et al. 1996; Kim et al. 2000). Vaccines
based on the latter proved safer due to higher tolerance by
humans (Larbig et al. 2001; Doring and Pier 2008). The
process of host colonization and further development of in-
fection rely on the proteins of the bacterial external cellular
membrane. The proteins interacting with the host’s tissues
initiate the degradation of physiological functions of the in-
vaded organism, stimulate the progression of infection, and
facilitate adaptation to the external environment (Lang 2000;
Lin et al. 2002). The proteins exposed on the cellular mem-
brane exhibit similar characteristics; however, it remains un-
clear whether they determine the course of infection. Most
probably, these proteins possess auxiliary function. Enolase is
a glycolytic enzyme present in eukaryotes and prokaryotes
(Seweryn et al. 2007, 2009). In humans, besides catalyzing
glycolysis and gluconeogenesis, it composes membranes of
epithelial and endothelial cells, monocytes, leucocytes, and
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neutrophiles where it acts as a receptor of human plas-
minogen (Pancholi and Fischetti 1998; Pancholi 2001;
Lopez-Alemany et al. 2003; Diaz-Ramos et al. 2012).
Plasminogen plays a crucial role in maintaining coagu-
lation homeostasis. Converted into active plasmin,
which in turn degrades fibrin, it allows the white blood
cells to migrate to the site of inflammation. The pres-
ence of protein receptors of plasminogen on the cellular
surface enables the invasive bacteria to employ the
fibrinolytic activity of plasmin and thus cleave the lam-
inin, fibronectin, proteoglycans, and other components
of human extracellular matrices (Kinloch et al. 2005;
Agarwal et al. 2008). The ability to transmigrate
through the layers of pulmonary epithelium and vascular
endothelium allows the bacteria to breach the tissue
barrier and colonize the host’s tissues.
Materials and methods
Obtaining and purification of the enolase-like surface protein
from P. aeruginosa cells
P. aeruginosa cells were cultured on tryptic soy agar (TSA)
solid medium for 48 h at the temperature of 37 °C. The
bacterial mass (18.7 g) was washed with pH 7.2, 10 mmol/L
Tris-HCl buffer with 3 mmol/L MgSO4, 1 % glycerol, and
0.5 mmol/L beta-mercaptoethanol and suspended in three
volumes of the same buffer containing also 4 μg/mL
phenylmethylsulfonyl fluoride (PMSF) and 0.2 μL/mL
aprotinin and was frozen in −80 °C. The purity of the culture
was assessed by microscopy and on agar plates. The separa-
tion of cellular structures was achieved with two freeze/thaw
cycles at −80 °C and room temperature. The sonicated mate-
rial was suspended in the following buffer: 10mmol/LTris-Cl,
pH 7.2, with 1 % glycerol, 3 mmol/L MgSO4, 0.5 mmol/L
beta-mercaptoethanol, 4 μg/mL PMSF, and 0.2 μL/mL
aprotinin. Undisrupted cells were removed by centrifugation
at 4,000 g, for 40 min at 4 °C. The resulting supernatant was
centrifuged at 120,000 g for 1 h at 4 °C in order to separate the
membrane fraction (precipitate) from the cytosolic one
(supernatant). The precipitate containing the membrane frac-
tion (external and cytoplasmic membranes) was extracted
twice in the following buffer A: 10 mmol/L Tris-Cl, pH 7.2,
with 1 % glycerol, 3 mmol/L MgSO4, 1 mmol/L beta-
mercaptoethanol, and 2 % Triton X-100, for 30 min at 20 °C
and centrifuged (120,000 g for 1 h at 4 °C). Next, in order to
rinse off proteins of external membranes, the precipitate was
extracted twice with buffer A containing 5 mmol/L EDTA
(buffer B) for 30 min at 20 °C and centrifuged (120,000 g for
1 h at 4 °C). The obtained supernatants from both extractions
were combined in buffer B and dialyzed into the following
buffer: 10 mmol/L Tris-Cl, pH 7.0, with 3 mmol/L MgSO4
and 1 mmol/L beta-mercaptoethanol, and subsequently con-
centrated by lyophilization. The obtained membrane proteins
were incubated once for 5 min at 100 °C with a reducing
buffer (50 mmol/L Tris-HCl (pH 6.8), 20 % glycerol, 5 %
sodium dodecyl sulfate (SDS), 0.005 % bromophenol blue,
10 % beta-mercaptoethanol) in the proportion 1:5 and sepa-
rated with the Prep-Cell 491 device (Bio-Rad) in polyacryl-
amide gel gradient: 50 mL of 10 % and 35 mL of 12 %
separating gel with 20 mL of 4 % condensing gel. The
proteins were separated at 250 V and 4 °C in an electrode
buffer: 25 mmol/LTris-HCl and 0.192 mol/L glycine, pH 8.3,
with 0.5 % SDS. Protein elution with the electrode buffer was
started once the bromophenol blue reached the basis of the
separating gel. Collected at the rate of 0.75 mL/min, 1.3-mL
fractions were subsequently poured into deionized water and
concentrated by lyophilization.
Immunoblotting identification of the enolase-like protein
The bacterial enolase-like protein was detected with rabbit
anti-human alpha-enolase antibodies obtained in our labora-
tory (data not shown). Once separated in polyacrylamide gel,
the proteins were transferred to the Immobilon P membrane.
The transfer fol lowed Witkowska ’s guidel ines
(Witkowska et al. 2005) in a transfer buffer (10 mmol/
L Tris, 150 mmol/L glycine, 20 % methanol) for
120 min at 200 mA. After the transfer, the membrane
was rinsed with water thrice in order to remove buffer
traces and stained with 0.005 % Ponceau S in 3 %
trichloroacetate with the aim to assess the quality of
protein separation and transfer. The membrane was
washed with deionized water. The membranes contain-
ing transferred proteins were incubated at 37 °C for 1 h
with rabbit anti-human alpha-enolase antibodies diluted
1:1,000 in TBS-T (20 mmol/L Tris-HCl, pH 7.0, with
50 mmol/L NaCl and 0.05 % Tween-20) with 1 %
bovine serum albumin (BSA). Unbound antibodies were
washed off with TBS (20 mmol/L Tris-HCl, pH 7.0,
with 50 mmol/L NaCl). Next, the membrane was incu-
bated at 37 °C for 1 h with goat anti-rabbit IgG anti-
bodies coupled with peroxidase.
Evaluation of enzymatic activity of surface proteins
of P. aeruginosa
Surface proteins of undisrupted cells were evaluated for
enolase-specific enzymatic activity as described by Pancholi
(Pancholi and Fischetti 1998). The evaluation was made on
bacterial cells in the phase of exponential growth. The bacteria
(counted according toMcFarland’s scale concentration, 1.95×
1010 per milliliter) were washed thrice with a reaction buffer
(100 mmol/L HEPES/NaOH, pH 7.2, with 10 mmol/L
MgSO4 and 7.7 mmol/L KCl) and suspended in different
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concentrations in 10 mL of reactive buffer. Enolase substrate
2-phosphoglycerate (2-PGA) was added to the samples at 6-
mmol/L concentration. For control, the bacteria were incubat-
ed under identical conditions without the substrate. The prod-
uct accumulation phosphoenolpyruvate (PEP) was assessed at
37 °C after 3-min-long incubation; the reaction was terminat-
ed by centrifugation (10,000 g for 1 min). The amount of
product in the resulting supernatant was assessed by spec-
trometry at 240 nm. For positive control, human α-enolase
(5 μg in 1 mL of reaction buffer) was incubated for 3 min with
2-PGA (6 mmol/L) and without substrate.
In vitro study of interaction between the enolase-like surface
protein and human plasminogen
Binding of human plasminogen by P. aeruginosa surface
enolase-like protein was assessed by immunoblotting. After
SDS-PAGE electrophoresis, the protein was transferred to a
PVDF membrane. Next, the membrane was incubated with
10 μg of plasminogen in 2 mL of TBS at 37 °C for 1 h.
Unbound plasminogen was washed off with TBS. A control
assay was carried out with rabbit anti-human plasminogen
antibodies instead of anti-alpha-enolase antibodies.
Sonication in buffer: 10 mmol/L Tris-Cl, pH 7.2 with 1% glycerol, 3 mmol/L MgSO4,
0.5 mmol/L 2-mercaptoethanol, 4 g/mL PMSF, 2 L/20 mL aprotinin
Centrifugation 4 000 g, 4 C, 40 min. 
supernatant




Extraction in buffer: 10 mmol/L Tris-Cl, pH 7.2 with 1% glycerol, 3 mmol/L MgSO4, 
1 mmol/L 2-mercaptoethanol, 2 % Triton X-100 (buffer A) in 20 C for 10 min.
Centrifugation 120 000 g, 4 C, 1 h 
pellet
Extraction in buffer A with 5 mmol/L EDTA (buffer B) in 20 C for 10 min.
Centrifugation 120 000 g, 4 C, 1 h supernatant
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Fig. 1 SDS-polyacrylamide gel
electrophoresis (a) and
immunoblot (b) of enolase-like
protein. 1 molecular mass protein
standards, 2 purified human α-
enolase from the kidney (5 μg), 3
outer membrane proteins after
extraction (150 μg), 4 enolase-
like protein after preparative
electrophoresis (10 μg)
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Localization of enolase-like surface receptors of P. aeruginosa
cells by electron microscopy
The P. aeruginosa cells (24-h-long culture in tryptic soy broth
(TSB) liquid medium) were washed off thrice with phosphate-
buffered saline (PBS) by centrifugation (5,000 g for 10 min at
4 °C). The pellet was blocked with 1 % BSA in 500 μL of
PBS for 30 min at 25 °C. The precipitate of bacterial cells was
subjected to immunocytochemical reaction with rabbit anti-
alpha-enolase polyclonal antibodies with 1 % BSA for 12 h.
Unbound antibodies were rinsed off with PBS by cen-
trifugation (thrice at 5,000 g for 10 min at 4 °C); next,
a marker was added—18-nm colloidal gold conjugated
with goat anti-rabbit IgG polyclonal antibodies diluted
1:10 in PBS with 1 % of BSA. After a 3-h incubation
at 25 °C, the excess of antibodies was washed off
(thrice with PBS), and 10 % BSA was added to the
pellet in 1:2 dilution for 2 h at 4 °C. Next, 10 %
formalin was added in 1:10 dilution. Once incubated
for 1 h at 4 °C, P. aeruginosa cells underwent dehydra-
tion in a series of alcohol/acetone baths. Once
dehydrated and saturated with Epon 812 and DMP-30
catalyst, the sample was polymerized at 60 °C for
10 days. The blocks were sliced with an ultramicro-
tome, stained with toluidine blue and evaluated under
JEOL 1011 transmission electron microscope.
Electron microscopy assay of plasminogen binding
by P. aeruginosa cells
P. aeruginosa cells (a 24-h culture in TSB liquid medium)
were rinsed off thrice with PBS by centrifugation at 5,000 g
for 10 min at 4 °C. The pellet was incubated with 30 μg of
plasminogen in 250 μg PBS; next, the unbound protein was
rinsed off thrice with PBS by centrifugation at 5,000 g for
10 min at 4 °C. Once blocked with 1 % BSA in 500 μL PBS
for 30 min at 25 °C, the sample was washed off thrice with
PBS by centrifugation at 5,000 g for 10 min at 4 °C. The
sediment of bacterial cells underwent immunocytochemical
reaction with rabbit anti-alpha-enolase polyclonal antibodies
diluted 1:10 in PBS with 1 % BSA for 12 h. The unbound
antibodies were washed off with PBS by centrifugation at
5,000 g for 10 min at 4 °C.
Results
Purification of the enolase-like surface protein
from P. aeruginosa cells
The purification method of P. aeruginosa surface enolase-like
protein involved the use of sonication, extraction, and prepar-
ative electrophoresis. The first step of isolating the surface
proteins was sonication of bacteria suspended in a buffer
containing a protease inhibitor. Next, the undisrupted cells
were removed by centrifugation, and the resulting supernatant
was ultracentrifuged with the aim to separate the cellular
membrane fraction from the cytosolic one. The resulting
sediment contained protein fractions bound to external and
cytoplasmic membranes. After undergoing extraction cycles
in detergent buffers containing a complexing compound (as in
Scheme 1), a mixture of P. aeruginosa external membrane
proteins was received (Fig. 1, row 3). Preparative electro-
phoresis for separation of membrane proteins and im-
munoblotting assay for detection allowed obtaining a
purified membrane protein of electrophoretic mobility
of 47 kDa and high reactivity with anti-alpha-enolase
antibodies. Figure 1a shows the purification level after
successive isolation stages, while Fig. 1b depicts the
reaction between the purified protein and antibodies.
Table 1 presents the protein purification balance.
Enzymatic activity of surface proteins of P. aeruginosa
Undisrupted cells of clinical strain resuspended in reactive
buffer were used to determine the enzymatic activity of the
bacterial enolase-like surface protein. Under these conditions,
no cell lysis was observed. Following incubation of the bac-
teria with substrate (2-PGA), the absorbance was measured
and compared with the control. The obtained results sug-
gest that the enolase-like surface protein of P. aeruginosa
does not exhibit enzymatic enolase activity (Table 2).
Also, no enolase enzymatic activity was detected among
the cytosolic fraction proteins.
Table 1 Purification result of enolase-like outer membrane protein from
18.7-g bacterial mass of Pseudomonas aeruginosa
Steps Protein mass (mg) Yield (%)
1 Cell extract 6,350 100
2 EDTA extraction, dialysis,
and lyophilization
547.8 8.62
3 Preparative electrophoresis 6.43 0.101
Table 2 Enolase activity of outer membrane proteins of intact Pseudo-
monas aeruginosa cells
Dilution of intact bacterial cells Control (A240) Test (A240) ΔA240
1:1 0.319±0.014 0.325±0.017 0.006
1:2 0.281±0.012 0.283±0.013 0.002
1:4 0.207±0.022 0.216±0.021 0.009
1:8 0.189±0.019 0.199±0.021 0.010
1:16 0.193±0.016 0.194±0.013 0.001
α-Enolase 0.089±0.015 1.06±0.051 0.967
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Interaction between the enolase-like surface protein
and human plasminogen
Immunoblotting assay allowed assessment of the
plasminogen-binding capacity of the enolase-like membrane
protein. Following electrophoresis, human alpha-enolase from
the kidney andmembrane enolase-like protein ofP. aeruginosa
were transferred to the Immobilon P membrane. Both proteins
exhibited reactivity with rabbit anti-alpha-enolase polyclonal
antibodies (Fig. 2a). The immunoblots, blocked with plasmin-
ogen and then treated with anti-alpha-enolase polyclonal an-
tibodies, revealed that P. aeruginosa membrane enolase-like
protein bound plasminogen and thus did not form complexes
with antibodies (Fig. 2b, row 3); however, no such interaction
has been observed in the case of alpha-enolase from the
human kidney (Fig. 2b, row 2). These results were confirmed
by an immunoblot incubated with plasminogen and subse-
quently developed with anti-plasminogen antibodies (Fig. 2c).
Localization of enolase-like surface receptors of P. aeruginosa
cells
Electronmicroscopy assay with the use of goat anti-rabbit IgG
antibodies conjugated with 18-nm colloidal gold allowed
localizing the enolase-like surface protein. The rabbit anti-
human alpha-enolase polyclonal antibodies bind to the
enolase-like protein on the bacterial surface (Fig. 3a).
However, bacterial cells blocked with human plasmino-
gen did not express any reaction with rabbit anti-human
alpha-enolase polyclonal antibodies. No complex
forming with antibodies conjugated with colloidal gold
was observed in the sample (Fig. 3b).











a b cFig. 2 Interaction of enolase-like
protein with plasminogen. 1
molecular mass protein standards,
2 purified human α-enolase
(10 μg), 3 purified enolase-like
protein (10 μg). a Immunoblot
with anti-α-enolase antibodies. b
Immunoblot with anti-α-enolase
antibodies after reaction with
plasminogen. c Immunoblot with
anti-plasminogen antibodies after
reaction with plasminogen
Fig. 3 Electron microscopic localization of enolase-like protein on the
surface of Pseudomonas aeruginosa cells using 18-ng gold particles
(magnification×60,000). a Reaction with anti-α-enolase antibodies. b
Reaction with anti-α-enolase antibodies after adding plasminogen
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Discussion
The outer membrane is the first line of defense for Gram-
negative bacteria against toxic compounds. The bacterial sur-
face components are immunologically important proteins be-
cause of their accessibility to host defense reaction. The pres-
ence of antibodies against alpha-enolase has been reported to
be associated with a diverse range of bacterial infections.
Antibodies against human and bacteria enolases have been
demonstrated to have cross-reactivity, suggesting that
pathogen-related enolase may be involved in the development
of autoimmune diseases (Liu and Shih 2007; Terrier et al.
2007). The alpha-enolase obtained from human tissue could
be used as a specific antigen for revealing circulating patho-
logic antibodies; furthermore, the production of specific rabbit
antibodies would allow the evaluation of possible cross-
reactivity withP. aeruginosa surface enolase-like protein. This
was the rationale for designing the method of obtaining alpha-
enolase from the organ which contains the enzyme in high
concentration, i.e., the human kidney. During evolution, the
human enolase preserved its highly conservative structure,
with the enzyme homology between the placental mammals
and other organisms reaching 50% (Piast et al. 2005; Seweryn
et al. 2007). Therefore, some structural similarity could be
anticipated between the human enolase and the enolase-like
proteins expressed on the surface of P. aeruginosa external
membranes, as described by Witkowska et al. (2005). In view
of these studies, it seemed important to examine whether the
enolase-like protein exhibited catalytic activity, despite the
fact that P. aeruginosa is a non-fermenting bacteria using the
Entner-Doudoroff pathway for oxidative catabolism. Our re-
sults have indicated that surface enolase-like protein does not
have catalytic activity. This fact suggested that this protein has
no catalytic center or that the center is unavailable to the
substrate. In the present study, by electron microscopy, we
have identified enolase-like protein on the surface of
P. aeruginosa. We have confirmed the similarity of epitopes
between the bacterial and human enolase. In fact, Bergmann
et al. and Yavlovich et al. have identified alpha-enolase on the
surface of Gram-positive bacteria such as Streptococcus
pneumoniae, Streptococcus pyogenes, Staphylococcus aureus,
and Mycoplasma fermentans (Bergmann et al. 2001;
Yavlovich et al. 2007; Diaz-Ramos et al. 2012). We have
identified for the first time on the surface of P. aeruginosa
(Gram-negative bacteria) enolase-like protein. Moreover, we
have obtained and purified this protein and described it. The
study of localizing the enolase-like protein has been carried
out on the surface of undisrupted bacterial cells by using
antibodies against human alpha-enolase. The binding of
enolase-like protein to plasminogen was demonstrated by
electron microscopy in an in vitro study. Interestingly, the
bacterial cells that have incubated with plasminogen did not
exhibit any interaction with antibodies against human alpha-
enolase. This result confirmed that the enolase-like protein on
the surface of P. aeruginosa possesses the ability to bind to
plasminogen. It was shown previously that surface proteins
exhibit receptor-like properties in S. pneumoniae, Streptococ-
cus mutans, Trichomonas vaginalis, and Bacillus anthracis
(Pancholi and Fischetti 1998; Bergmann et al. 2001; Whiting
et al. 2002; Ge et al. 2004; Agarwal et al. 2008; Mundodi et al.
2008). Plasminogen, in turn, allows it to invade tissues con-
tributing to its pathogenicity. Proteolytic activation of plasmin-
ogen results in the formation of plasmin that degrades fibrin
and ECM proteins (Diaz-Ramos et al. 2012). In conclusion, we
have demonstrated for the first time, to our knowledge, that
P. aeruginosa enolase-like protein has affinity for human plas-
minogen. Our results indicate that the surface enolase of a
bacterium could be a key molecule in pathogenesis by facili-
tating bacterial interaction with host cells. Binding of plasmin-
ogen via enolase-like surface protein to the surface of
P. aeruginosa may therefore facilitate invasion of host tissue.
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